Tirzepatide (5mg/0.5ml) is manufactured by Eli Lilly and Company India Pvt Ltd
This is available in a 1 Vial of 0.5 Ml format with an MRP of ₹4375.
If you experience any persistent or severe side effects, consult your doctor immediately.
Alcohol Should Be Used With Caution While Taking Mounjaro 5Mg Solution For Injection.
It Is Not Known Whether Mounjaro 5Mg Solution For Injection Alters The Ability To Drive. Do Not Drive If You Experience Any Symptoms That Affect Your Ability To Concentrate And React. Please Consult Your Doctor.
Mounjaro 5Mg Solution For Injection Should Be Used With Caution In Patients With Kidney Disease. Dose Adjustment May Be Needed.
Mounjaro 5Mg Solution For Injection Should Be Used With Caution In Patients With Liver Disease. Dose Adjustment May Be Needed.
Mounjaro 5Mg Solution For Injection Is Not Recommended During Pregnancy As There Is Positive Evidence Of Fetal Risk Based On Animal Studies. However It May Still Be Prescribed By A Doctor In Situations Where The Benefits Outweigh The Risks. Additionally Mounjaro 5Mg Solution For Injection May Reduce The Effectiveness Of Oral Hormonal Contraceptives Due To Delayed Gastric Emptying. Patients Using Oral Contraceptives Should Either Switch To A Non-Oral Contraceptive Method Or Use An Additional Barrier Method (E.G. Condoms) For 4 Weeks After Starting Mounjaro 5Mg Solution For Injection And For 4 Weeks After Each Dose Escalation.
Mounjaro 5Mg Solution For Injection Should Be Used With Caution During Breastfeeding. Breastfeeding Should Be Held Until The Treatment Of The Mother Is Completed And The Drug Is Eliminated From The Body. They Will Weigh Its Benefits Against Potential Risks To The Infant And Advise You Accordingly.








100% Genuine
Medicines
No
Return
Online
Payment Only
Eli Lilly and Company India Pvt Ltd
1 Vial of 0.5 Ml
100% Genuine
Medicines
No
Return
Online
Payment Only
Eli Lilly and Company India Pvt Ltd
1 Vial of 0.5 Ml